DrugPatentWatch Database Preview
Profile for Japan Patent: 4733037
US Patent Family Members and Approved Drugs for Japan Patent: 4733037
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | May 15, 2023 | Celgene | POMALYST | pomalidomide |
➤ Sign Up | Oct 7, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Sign Up | Oct 19, 2024 | Celgene | POMALYST | pomalidomide |
➤ Sign Up | Jun 17, 2025 | Celgene | POMALYST | pomalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |